Season 1
S1, E6: Alltrna and tRNA therapeutics for rare genetic diseases with CEO Michelle Werner and rare diseases expert Dr David Weinstein
In this episode of Raising Biotech, Surani explores the untapped world of tRNA therapeutics with Flagship Pioneering-founded company Alltrna. The company raised $109 million in a series B in August 20...
S1, E5: Arialys and a neuropsychiatry drug revival with CEO Jay Lichter and experts Marty Jefson (Pinteon) and Dr Leon Henderson-MacLennan (InThought)
In this episode of Raising Biotech, Surani delves into Arialys and its mission to revive an autoimmune encephalitis drug from the grave after big pharma no longer wanted it. The company founders are a...
S1, E4: Synchron and breakthrough brain implants with CEO Dr Tom Oxley, CCO Kurt Haggstrom and experts Dr Elad Levy (UB), Dr David Putrino (Mount Sinai)
In this episode of Raising Biotech, Surani delves into Synchron and its mission to develop a potential first-in-class implantable brain computer interface (BCI) that allows people with motor impairmen...
S1, E3: eGenesis and xenotransplantation with CEO Mike Curtis and Dr Adam Griesemer, NYU
In this episode of Raising Biotech, Surani Fernando speaks with eGenesis CEO Mike Curtis on its mission to create pig donor organs for humans waiting for a transplant. The company has raised $263 mill...
S1, E2: Ochre Bio with CEO/Co-founder Jack O'Meara and liver expert Dr Scott Friedman, Mount Sinai
In this episode of Raising Biotech, Surani speaks with CEO and co-founder Jack O'Meara of Ochre Bio, a company dedicated to tackling the large and unsolved problem of complex and chronic liver disease...
S1, E1: Empress Therapeutics with CEO/Co-founder Jason Park + experts Prof Jim Collins, MIT and Dr Leon Henderson-MacLennan, InThought
In the first episode of Raising Biotech, Surani speaks with CEO and co-founder Jason Park of Empress Therapeutics, a Flagship Pioneering company that was unveiled in June 2023 with a $50 million finan...
